Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients
- 25 January 2005
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 13 (4) , 266-269
- https://doi.org/10.1007/s00520-004-0726-y
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositisCancer, 2004
- Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortalityBlood, 2002
- Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myelomaBone Marrow Transplantation, 2002
- Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myelomaBlood, 2002
- Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplantBone Marrow Transplantation, 2001
- Ice pops to prevent melphalan-induced stomatitisThe Lancet, 1996
- Prevention of high dose L-PAM-induced mucositis by cryotherapy.1994
- Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitisOral Oncology, 1994
- Inhibition of fluorouracil-induced stomatitis by oral cryotherapy.Journal of Clinical Oncology, 1991
- Pharmacokinetics of high-dose melphalan in children and adultsCancer Chemotherapy and Pharmacology, 1986